Zidovudine should be given before HIV-positive individuals develop symptoms

This publication has 29 references indexed in Scilit:

• Resistance of clinical isolates of human immunodeficiency virus to antiretroviral agents
  Antimicrobial Agents and Chemotherapy, 1993
• 2',3'-Didehydro-3'-deoxythymidine (d4T) in Patients with AIDS or AIDS-Related Complex: A Phase I Trial
  The Journal of Infectious Diseases, 1993
• A Controlled Trial of Early versus Late Treatment with Zidovudine in Symptomatic Human Immunodeficiency Virus Infection
  New England Journal of Medicine, 1992
• A Randomized Controlled Trial of a Reduced Daily Dose of Zidovudine in Patients with the Acquired Immunodeficiency Syndrome
  New England Journal of Medicine, 1990
• The Safety and Efficacy of Zidovudine (AZT) in the Treatment of Subjects with Mildly Symptomatic Human Immunodeficiency Virus Type 1 (HIV) Infection
  Annals of Internal Medicine, 1990
• Zidovudine in Asymptomatic Human Immunodeficiency Virus Infection
  New England Journal of Medicine, 1990
• Prolonged Zidovudine Therapy in Patients With AIDS and Advanced AIDS-Related Complex
  Published by American Medical Association (AMA) ,1989
• EFFECTS OF ZIDOVUDINE IN 365 CONSECUTIVE PATIENTS WITH AIDS OR AIDS-RELATED COMPLEX
  The Lancet, 1988
• RESUMPTION OF HIV ANTIGEN PRODUCTION DURING CONTINUOUS ZIDOVUDINE TREATMENT
  The Lancet, 1988
• The Efficacy of Azidothymidine (AZT) in the Treatment of Patients with AIDS and AIDS-Related Complex
  New England Journal of Medicine, 1987